New Epilepsy Center Opens at Hadassah
A new Interdisciplinary center for the treatment of Epilepsy in children and adults was opened at Hadassah Medical Center. It includes a team of Pediatric and Adult Neurologists, Neurosurgeons, Psychiatrists, Neuropsychologists, Radiologists, Nuclear Medicine experts, Nutrition Specialists, Researchers and more.Epilepsy is a common disease that affects approximately 0.7% of the population including children and adults. It is estimated that there are around 7000 epilepsy patients in Jerusalem alone, and each year around 500 more people are diagnosed. With the right treatment 70% of the patients become seizure free and are able to lead completely normal lives.
Patients who continue to suffer from seizures despite medical therapy can benefit from non-drug treatments through surgery such as the implantation of a pacemaker or other procedures. Due to the complexity of the disease experts in the various aspects of epilepsy are required for its diagnosis and "Many patients suffering from seizures (often for years) or from side effects of anticonvulsant therapy are not aware that there is a possibility of improving their condition" says Doctor Dana Eckstein from the Neurology Department at Hadassah, who coordinates the new Center's activities "Therefore it is extremely important to raise awareness to the general public and medical community about the need for an epilepsy specialty center at which advanced evaluation and treatment for even the most difficult cases are made possible", She adds.
This center holds itself to the highest standard in diagnosis and treatment of patients with epilepsy of varying severity through advanced technical measures as in centers in the western world. In addition to the advanced medical treatment of patients, it supports hi level research in collaboration with researchers from the Hebrew University and other leading institutions worldwide and promotes continued research in brain diseases and epilepsy in particular. These studies are expected to contribute to the treatment of neurological and psychiatric diseases and lead to a breakthrough in neuroscience.
Ron KrumerDate: 3/22/2012 12:00:00 AM
Director, External Relations
Hadassah Medical Organization